
Security Check Required




FacebookJoin or Log Into Facebook   Email or PhonePasswordForgot account?Log InDo you want to join Facebook?Sign UpSign UpSecurity CheckPlease enter the text belowCan't read the text above?Try another text or an audio captchaText in the box:What's this?Security CheckThis is a standard security test that we use to prevent spammers from creating fake accounts and spamming users.SubmitEnglish (US)EspañolFrançais (France)中文(简体)العربيةPortuguês (Brasil)Italiano한국어Deutschहिन्दी日本語MessengerFacebook LitePeoplePlacesGamesLocationsCelebritiesMarketplaceGroupsRecipesMomentsInstagramAboutCreate AdCreate PageDevelopersCareersPrivacyCookiesAd ChoicesTermsSettingsActivity Log Facebook © 2017


    Jillian Thomsen | Nektar Therapeutics | ZoomInfo.com
Jillian Thomsen Profiles | Facebook

FacebookEmail or PhonePasswordForgot account?English (US)EspañolFrançais (France)中文(简体)العربيةPortuguês (Brasil)Italiano한국어Deutschहिन्दी日本語MessengerFacebook LitePeoplePlacesGamesLocationsCelebritiesMarketplaceGroupsRecipesMomentsInstagramAboutCreate AdCreate PageDevelopersCareersPrivacyCookiesAd ChoicesTermsSettingsActivity Log Facebook © 2017


















 











 


 

Jillian B. Thomsen's involvement in venture capital (via Nektar Therapeutics)































Want to see more?Want to find out who got funded, and who’s funding the next big thing? in real time? all across the world? tailored to your specific areas of focus?100+ deals per dayGet access to the most exhaustive worldwide funding watch on the web!Comprehensive funding informationKnow about who invested in a company, which sites covered the event, the funding history, etc.Exclusive insightsView original analytics such as most dynamic industries, most active investors, and more!Stay aware!Get emailed when deals critical to your business happen. Filter by region, industry and topics of interest.As seen onHave a login?Sign inRegister now!It's free!Use your social accountOr fill in the quick form:Register nowpromise we won't spamSign invia your social account:via your existing WGF account:Remember meRegister, it's freeForgot your password?SIGN INForgot your password?Enter your e-mail and we will send you your new password.reset passwordThe world's largest funding base/people/191176-b-thomsen-jilliansection=people&subsection=detail&id=191176




			Search deals by company name, industry, location, investors...			
			




SEARCH


JillianB. ThomsenGet alertedif Jillian B. Thomsen gets funded!Jillian B. ThomsenNektar Therapeutics - Senior Vice President, Finance and Chief Accounting OfficerDeals involving Jillian B. Thomsen$175,500,000 raised with Nektar Therapeutics on October, 2016$108,400,000 raised with Nektar Therapeutics on January, 2014Please note that all data is automatically extracted and errors can occur.The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.Some of the profile information was collected using the Crunchbase API. For more details on the profile, please check Jillian B. Thomsen on Crunchbase.Inaccurate Data? Help us improve WhoGotFunded: post a comment! 

Jillian B. Thomsen's involvement in venture capital (via Nektar Therapeutics)































Want to see more?Want to find out who got funded, and who’s funding the next big thing? in real time? all across the world? tailored to your specific areas of focus?100+ deals per dayGet access to the most exhaustive worldwide funding watch on the web!Comprehensive funding informationKnow about who invested in a company, which sites covered the event, the funding history, etc.Exclusive insightsView original analytics such as most dynamic industries, most active investors, and more!Stay aware!Get emailed when deals critical to your business happen. Filter by region, industry and topics of interest.As seen onHave a login?Sign inRegister now!It's free!Use your social accountOr fill in the quick form:Register nowpromise we won't spamSign invia your social account:via your existing WGF account:Remember meRegister, it's freeForgot your password?SIGN INForgot your password?Enter your e-mail and we will send you your new password.reset passwordThe world's largest funding base/people/191176-jillian-b-thomsensection=people&subsection=detail&id=191176




			Search deals by company name, industry, location, investors...			
			




SEARCH


JillianB. ThomsenGet alertedif Jillian B. Thomsen gets funded!Jillian B. ThomsenNektar Therapeutics - Senior Vice President, Finance and Chief Accounting OfficerDeals involving Jillian B. Thomsen$175,500,000 raised with Nektar Therapeutics on October, 2016$108,400,000 raised with Nektar Therapeutics on January, 2014Please note that all data is automatically extracted and errors can occur.The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.Some of the profile information was collected using the Crunchbase API. For more details on the profile, please check Jillian B. Thomsen on Crunchbase.Inaccurate Data? Help us improve WhoGotFunded: post a comment!


Insider Trading - Thomsen Jillian B. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Thomsen Jillian B.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-11-16Sale
2016-11-186:12 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
1,986
$13.96
$27,725
42,102(Direct)
View


2016-08-16Sale
2016-08-175:42 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
3,971
$17.56
$69,731
44,088(Direct)
View


2016-07-11Sale
2016-07-135:08 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
100,000
$15.09
$1,509,000
106,809(Direct)
View


2016-05-16Sale
2016-05-185:08 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
724
$13.58
$9,832
18,750(Direct)
View


2016-03-09Sale
2016-03-115:06 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$11.79
$176,850
20,158(Direct)
View


2016-02-16Sale
2016-02-187:46 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
716
$11.92
$8,535
20,625(Direct)
View


2016-02-10Sale
2016-02-125:19 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$11.49
$172,350
18,999(Direct)
View


2016-01-19Sale
2016-01-216:06 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$14.12
$211,800
30,000(Direct)
View


2015-12-03Sale
2015-12-075:29 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$15.87
$238,050
45,000(Direct)
View


2015-11-11Sale
2015-11-134:12 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$13.52
$202,800
60,000(Direct)
View


2015-10-06Sale
2015-10-087:09 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$10.99
$164,850
75,000(Direct)
View


2015-09-23Sale
2015-09-255:25 pm
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
10,000
$13.04
$130,400
90,000(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-13Option Award
2016-12-158:47 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$0
57,602(Direct)
View


2016-12-13Option Award
2016-12-158:47 pm
N/A2024-12-12
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
37,500
$12.24
57,602(Direct)
View


2016-07-14Option Award
2016-07-185:10 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
22,500
$0
50,000(Direct)
View


2016-07-14Option Award
2016-07-185:10 pm
N/A2022-12-08
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
50,000
$16.31
50,000(Direct)
View


2016-07-14Option Award
2016-07-185:10 pm
N/A2023-12-14
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
18,750
$15.55
50,000(Direct)
View


2016-07-11Exercise
2016-07-135:08 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
100,000
$4.65
106,809(Direct)
View


2016-07-11Exercise
2016-07-135:08 pm
2013-02-232017-02-22
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
100,000
$4.65
106,809(Direct)
View


2016-05-16Exercise
2016-05-185:08 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
1,875
$0.0001
18,750(Direct)
View


2016-05-16Disposition
2016-05-185:08 pm
2016-05-162016-05-16
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
1,875
$0.0001
18,750(Direct)
View


2016-03-09Exercise
2016-03-115:06 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
20,158(Direct)
View


2016-03-09Exercise
2016-03-115:06 pm
2012-03-202016-03-19
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
20,158(Direct)
View


2016-02-16Exercise
2016-02-187:46 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
1,875
$0.0001
20,625(Direct)
View


2016-02-16Disposition
2016-02-187:46 pm
2016-02-162016-02-16
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
1,875
$0.0001
20,625(Direct)
View


2016-02-10Exercise
2016-02-125:19 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
18,999(Direct)
View


2016-02-10Exercise
2016-02-125:19 pm
2012-03-202016-03-19
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
18,999(Direct)
View


2016-01-19Exercise
2016-01-216:06 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
30,000(Direct)
View


2016-01-19Exercise
2016-01-216:06 pm
2012-03-202016-03-19
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
30,000(Direct)
View


2015-12-15Option Award
2016-01-154:44 pm
N/A2023-12-14
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
22,500
$0
22,500(Direct)
View


2015-12-15Option Award
2016-01-154:44 pm
N/A2023-12-14
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
18,750
$15.55
22,500(Direct)
View


2015-12-15Option Award
2015-12-176:47 pm
N/A2023-12-14
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
18,750
$0
22,500(Direct)
View


2015-12-15Option Award
2015-12-176:47 pm
N/A2023-12-14
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
22,500
$15.55
22,500(Direct)
View


2015-12-03Exercise
2015-12-075:29 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
45,000(Direct)
View


2015-12-03Exercise
2015-12-075:29 pm
2012-03-202016-03-19
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
45,000(Direct)
View


2015-11-11Exercise
2015-11-134:12 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
60,000(Direct)
View


2015-11-11Exercise
2015-11-134:12 pm
2012-03-202016-03-19
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
60,000(Direct)
View


2015-10-06Exercise
2015-10-087:09 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
75,000(Direct)
View


2015-10-06Exercise
2015-10-087:09 pm
2012-03-202016-03-19
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
15,000
$6.65
75,000(Direct)
View


2015-09-23Exercise
2015-09-255:25 pm
N/AN/A
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
10,000
$6.65
90,000(Direct)
View


2015-09-23Exercise
2015-09-255:25 pm
2012-03-202016-03-19
Nektar Therapeutics
NKTR
Thomsen Jillian B.SVP & Chief Accounting Officer
10,000
$6.65
90,000(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 20:06:26 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  











NKTR Jillian B. Thomsen Insider Trades for Nektar Therapeutics


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Nektar Therapeutics

                  NASDAQ: NKTR
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Nektar Therapeutics



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:48 p.m.


NKTR

/quotes/zigman/89920/composite


$
22.84




Change

-0.07
-0.30%

Volume
Volume 22,293
Quotes are delayed by 20 min








/quotes/zigman/89920/composite
Today's close

$
			22.61
		


$
				22.91
			
Change

+0.30
+1.33%





Day low
Day high
$22.26
$22.99










52 week low
52 week high

            $11.41
        

            $24.88
        


















Insider Activity


Individual




Jillian B. Thomsen



Ms. Jillian B. Thomsen, CPA, is Chief Accounting Officer & Senior VP-Finance at Nektar Therapeutics. 
Ms. Thomsen was previously employed as VP-Finance & Deputy Corporate Controller by Calpine Corp. and Senior Manager by Arthur Andersen LLP. 
She received her undergraduate degree from Colorado College and a graduate degree from the University of Denver.



Transactions


Date
Shares
Transaction
Value





05/16/2017
2,651


 
Disposition at $19.55 per share.


51,828


03/20/2017
112,500


 
Disposition at $19.69 per share.


2,215,125


03/20/2017
37,500


 
Derivative/Non-derivative trans. at $7.21 per share.


270,375


03/20/2017
75,000


 
Derivative/Non-derivative trans. at $11.34 per share.


850,500


02/16/2017
1,965


 
Disposition at $13.14 per share.


25,821


12/13/2016
15,000


 
Award at $0 per share.


0


11/16/2016
1,986


 
Disposition at $13.96 per share.


27,725


08/16/2016
3,971


 
Disposition at $17.56 per share.


69,731


07/14/2016
22,500


 
Award at $0 per share.


0


07/11/2016
100,000


 
Disposition at $15.09 per share.


1,509,000


07/11/2016
100,000


 
Derivative/Non-derivative trans. at $4.65 per share.


465,000


05/17/2016
724


 
Disposition at $13.58 per share.


9,832


05/16/2016
1,875


 
Derivative/Non-derivative trans. at $0 per share.


0


03/09/2016
15,000


 
Disposition at $11.79 per share.


176,850


03/09/2016
15,000


 
Derivative/Non-derivative trans. at $6.65 per share.


99,750


02/17/2016
716


 
Disposition at $11.92 per share.


8,535


02/16/2016
1,875


 
Derivative/Non-derivative trans. at $0 per share.


0


02/10/2016
15,000


 
Disposition at $11.49 per share.


172,350


02/10/2016
15,000


 
Derivative/Non-derivative trans. at $6.65 per share.


99,750


01/19/2016
15,000


 
Disposition at $14.12 per share.


211,800


01/19/2016
15,000


 
Derivative/Non-derivative trans. at $6.65 per share.


99,750


12/03/2015
15,000


 
Disposition at $15.87 per share.


238,050


12/03/2015
15,000


 
Derivative/Non-derivative trans. at $6.65 per share.


99,750


11/11/2015
15,000


 
Disposition at $13.52 per share.


202,800


11/11/2015
15,000


 
Derivative/Non-derivative trans. at $6.65 per share.


99,750


10/06/2015
15,000


 
Disposition at $10.99 per share.


164,850


10/06/2015
15,000


 
Derivative/Non-derivative trans. at $6.65 per share.


99,750


09/23/2015
10,000


 
Disposition at $13.04 per share.


130,400


09/23/2015
10,000


 
Derivative/Non-derivative trans. at $6.65 per share.


66,500


12/22/2014
5,000


 
Disposition at $15.56 per share.


77,800


12/22/2014
5,000


 
Derivative/Non-derivative trans. at $11.38 per share.


56,900





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Howard W. Robin 
President, Chief Executive Officer & Director




Mr. John  Nicholson 
Chief Operating Officer & Senior Vice President




Mr. Gilbert M. Labrucherie 
Chief Financial Officer & Senior Vice President




Dr. Ivan Philip Gergel 
Chief Medical Officer & Senior VP-Drug Development




Dr. Stephen K. Doberstein 
Chief Scientific Officer & Senior Vice President




Dr. Mary  Tagliaferri 
Vice President-Clinical Development




Dr. Maninder  Hora 
Senior Vice President-Pharmaceutical Development




Ms. Jillian B. Thomsen 
Chief Accounting Officer & Senior VP-Finance




Ms. Jennifer  Ruddock 
Senior VP-Investor Relations & Corporate Affairs




Ms. Jodi A. Sievers 
Director-Investor Relations & Communications




Ms. Dorian  Hirth 
Senior VP-Human Resources & Facilities Operations




Mr. Mark A Wilson 
Secretary, Vice President & General Counsel




Dr. Carlo J. Di Fonzo 
Senior VP-Drug Development & Regulatory Affairs




Mr. Robert B. Chess 
Chairman




Mr. Joseph J. Krivulka 
Independent Director




Mr. R. Scott Greer 
Independent Director




Mr. Dennis L. Winger 
Independent Director




Mr. Roy A. Whitfield 
Independent Director




Mr. Christopher A. Kuebler 
Independent Director




Mr. Lutz  Lingnau 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




9:06 PM EDT
July 28, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
7:48pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
7:39pBarron's Buzz: Robo 2.0, Facebook and Twitter, Trading On News
7:29pA Wild Week in Washington 
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15























































Jillian B. Thomsen , Nektar Therapeutics - Leadership® Profile

































Products


Resources


About 


Client Support


Order








Leadership® ProfileLast changed: 7/25/2017  
Jillian B. Thomsen  
Senior Vice President, Finance and Chief Accounting OfficerNektar Therapeutics
Telephone, Email, and Fax available

Total Positions available: 1



 Purchase This Profile
Request Free Trial


Subscribe to one of these Leadership® Online products for unlimited access:
Leadership® Health Focus Leadership Networks®


About Leadership Directories, Inc. [LDI]

	Leadership Directories, Inc. [LDI] is a B2B information services company which provides premium content and contact solutions. LDI researches and publishes verified profiles of influential people and organizations from the federal government, state and local governments, public and private companies, law firms and courts, media outlets, healthcare organizations, nonprofits and associations, and the U.S. Congress.LDI's unique database of 900,000 contacts and 165,000 organizations is available online, in print, and as custom data services. Our high-quality data is updated daily with 4,000+ changes verified by NYC- and DC-based staff.


 




                Toll free: 1-800-627-0311

                1407 Broadway, Suite 318, New York, NY 10018
Tel: (212) 627-4140     Fax: (212) 645-0931
            

                1667 K Street, NW, Suite 801, Washington, DC 20006
Tel: (202) 347-7757       Fax:
                (202) 628-3430
            




Terms of use

|

Privacy Policy

|

FAQ

|

Contact us


 ©  Leadership Directories, Inc.
            





